Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Aug 19.
Published in final edited form as: Immunol Res. 2011 Apr;49(0):173–191. doi: 10.1007/s12026-010-8180-z

Ambient ozone and pulmonary innate immunity

Mashael Al-Hegelan 1, Robert M Tighe 1, Christian Castillo 1, John W Hollingsworth 1,2
PMCID: PMC3747041  NIHMSID: NIHMS495256  PMID: 21132467

Abstract

Ambient ozone is a criteria air pollutant that impacts both human morbidity and mortality. The effect of ozone inhalation includes both toxicity to lung tissue and alteration of the host immunologic response. The innate immune system facilitates immediate recognition of both foreign pathogens and tissue damage. Emerging evidence supports that ozone can modify the host innate immune response and that this response to inhaled ozone is dependent on genes of innate immunity. Improved understanding of the complex interaction between environmental ozone and host innate immunity will provide fundamental insight into the pathogenesis of inflammatory airways disease. We review the current evidence supporting that environmental ozone inhalation: (1) modifies cell types required for intact innate immunity, (2) is partially dependent on genes of innate immunity, (3) primes pulmonary innate immune responses to LPS, and (4) contributes to innate-adaptive immune system cross-talk.

Keywords: environmental, toll-like receptor, TLR4, CD44, hyaluronan, asthma, genetic, gene x environment

AMBIENT OZONE IS AN IMPORTANT PUBLIC HEALTH CONCERN

Ozone is an ambient gas, composed of three oxygen atoms, that is formed through a chemical reaction between oxides of nitrogen and volatile organic compounds in the presence of sunlight. Since the Clean Air Act of 1970, the EPA has identified ambient ozone as a criteria pollutant with adverse health effects. Inhalation of ozone significantly contributes to both human morbidity and mortality and is estimated to account for approximately 800 premature deaths, 4,500 hospital admission and 900,000 school absences annually. It causes more than a million days of restricted activity with an annual economic burden estimated at $5 billion1. Particularly vulnerable populations include; individuals with underlying respiratory disease (asthma, COPD), children, and adults over the age of 65. There does not appear to be a threshold level of ozone below which there are no detrimental health effects24. Each 10ppb increase in daily ozone is associated with an approximately 0.87% increase in total mortality5. Therefore, stricter regulatory standards would not be predicted to completely eradicate the adverse health effects of ambient ozone. Furthermore, it is anticipated that the levels of ambient ozone will increase with climate change67, which will present new challenges to enforcing current regulatory standards and could have substantial impact on global health. Independent of our ability to lower ground-level ozone concentrations, understanding mechanisms by which inhalation of ambient ozone adversely impacts human health will greatly improve our ability to treat airways disease.

AMBIENT OZONE AND IMMUNOLOGY

The lung is uniquely vulnerable to ambient toxicants by virtue of its continuous exposure to the external environment. Inhalation of ambient ozone exacerbates respiratory disease and can modify both the innate and adaptive immune responses. A growing body of evidence exists supporting the ability of ambient ozone to not only cause direct tissue injury through generation of reactive oxygen species, but also to modify complex immunological responses. Ambient ozone can modify the function of many cell types within the lung which are critical regulators of both innate and adaptive immunological responses.

The pulmonary immune surveillance system is highly efficient in eradicating inhaled foreign material and pathogens. Protection of the host is facilitated through a complex interaction between effective barrier function, innate immunity, and acquired/adaptive immunologic responses. Early studies of health effects of ozone inhalation were focused on either defects in epithelial barrier function or adaptive/acquired immunity. Recent evidence supports a role for genes of innate immunity in the response to inhaled ambient ozone. We now appreciate that the response to ambient ozone is dependent on a complex interaction between both innate and adaptive immunity. The innate immune system is a highly conserved evolutionary system used to identify threatening microorganisms. The innate immune system is activated through a combination of direct pathogen recognition, by pathogen-associated molecular patterns (PAMP), and through recognition of host factors associated with tissue damage or damage-associated molecular patterns (DAMP). PAMPs and DAMPs are recognized by germ-line encoded receptors of innate immunity and are broadly classified as pattern recognition receptors (PRR). The primary focus of this review is to understand the interaction between inhalation of ambient ozone and host innate immunity (Figure 1).

Figure 1. Ozone alters many cell types in the lung and modifies pulmonary innate immunity.

Figure 1

(A) Many cell types are modified by inhalation of ozone. Inhalation of ozone can lead to increase numbers of macrophages, neutrophils, and dendritic cells in the lung. Ozone disrupts airway epithelia cells including; impaired barrier function, injury to cilia, impaired mucociliary clearance, and alters production of cytokines. Ozone can impair macrophage phagocytosis, induce cytokine expression, induce apoptosis, and alter expression of genes of innate immunity. (B) The response to ozone is dependent on genes of innate immunity and can enhance surface expression of TLR4 on macrophages. Current evidence supports a role of both macrophages and airway epithelia in the complete innate immune response to ozone. Ozone induces fragmentation of extracellular matrix hyaluronan (HA) into low molecular weight (LMW). HA fragments result in TLR4-dependent and CD44-dependent production of pro-inflammatory cytokines. The response to ozone supports a role of both MyD88 and NF-kB in the production of pro-inflammatory cytokines.

MULTIPLE CELL TYPES REQUIRED FOR INTACT INNATE IMMUNITY ARE MODIFIED BY OZONE INHALATION

Pulmonary innate immunity is dependent on a complex signaling network between many cell types8. Our basic understanding of this signal network has been derived primarily by studies analyzing the effects of bacterial lipopolysaccharide (LPS) binding to the surface PRR, toll-like receptor 4 (TLR4). LPS stimulation through TLR4 causes activation of NF-κB and directs a cascade of pro-inflammatory events directed towards effective antibacterial host defense. It is increasingly evident that many cell types within the lung express TLR4 and can respond to stimulation by TLR4 ligands9. Hematopoietic-derived, TLR4-expressing cells in the lung include; macrophages10, neutrophils11, lymphocytes12, and dendritic cells13. In addition, non-hematopoietic-derived cells, such as airway epithelia1416 and endothelia17 both express TLR4 and can respond to stimulation by LPS. While the complete signaling network required for intact innate immunity remains elusive, it is clear that inhalation of ozone can modify many cell types required for this signaling network. To facilitate a better understanding of the potential mechanisms by which ozone can modify pulmonary innate immunity, we review the current understanding of the effects of ozone on each relevant cell type.

Airway Epithelia

Airway epithelium is of critical importance to innate defense in the lung. It functions as both a barrier and a as regulator of immune response. Acute inhalation of ozone causes direct damage to airway epithelia resulting in loss of cilliary function18, increased airway epithelial permeability1920, and defects in mucocilliary clearance21. These structural alterations in the respiratory epithelium contribute to impaired clearance of foreign material and microbes, thereby enhancing vulnerability to pulmonary infections.

In addition to its barrier function, the epithelium has a direct role in regulating the innate immune response2223. Toll-like receptors are expressed on the surface of epithelial cells2425. Despite this expression, the functional role of TLR receptors on airway epithelia remains somewhat unclear. There appear to be both direct and indirect mechanisms of activating airway epithelia dependent on the type of environmental challenge. Ozone can activate innate immune signaling in airway epithelia but also involves multiple mechanisms. Similar to human exposures26, in vitro stimulation of immortalized human epithelial cell lines with ozone resulted in production of interleukin 6 (IL-6) and interleukin 8 (IL-8) under most2731, but not all experimental conditions3233. Given the high reactivity of ozone and low solubility in media, it remains unclear whether the effects of ozone on epithelia are direct or indirect34. Ozone-induced modification of lipids can act as signal transduction molecules3536 and more recent observations support an indirect effect of ozone on epithelia through macrophage-derived IL-1α37. The latter findings support cross-talk between macrophages and epithelial cells in responses to inhaled ozone. Regardless of the specific mechanism, it is clear that airway epithelia are an important cell type for innate immune response and can be affected by exposure to ozone.

Macrophages

Growing evidence supports the importance of macrophages in pulmonary innate immunity. Macrophages appear exquisitely sensitive to ozone38. Early results demonstrated that in vitro exposure of human alveolar macrophages to ozone resulted in decreased phagocytosis of particulate immune complexes, enhanced production of prostaglandin E2, increased superoxide production39, and impaired antimicrobial host defense4041. However, additional studies of direct ozone exposure to alveolar macrophages, generate inconsistent results with either enhanced4244 or reduced cytokine production27, 4546. It is unclear whether in vitro exposures reconstitute the complete biological response to ozone, as many factors observed in the bronchial alveolar lavage (BAL) fluid after ozone inhalation are derived from other cell types or the extracellular environment. For example, our recent studies support that ozone-induced lung injury is associated with increased levels of the damage-associated molecular pattern (DAMP), hyaluronan, which can induce macrophage-derived production of pro-inflammatory cytokines47. Together, these findings suggest that macrophages are not only sensitive to direct exposure to ozone and but can also undergo indirect stimulation through soluble mediators released after inhalation of ozone.

Ozone inhalation can also enhance the expression of macrophage pattern recognition receptors. For example, macrophage receptor with collagenous structure (marco) is increased on alveolar macrophages after ozone exposure and functions to promote the uptake of surfactant-derived oxidation products in the epithelial lining fluid4849. Deficiency of marco resulted in enhanced oxidative stress and worsening airway hyperresponsiveness (AHR). This study suggest that inhalation of ozone can enhance lung macrophage antioxidant function through a new population of macrophages that express the scavenger receptor marco. This finding suggests a protective role for lung macrophages after ozone exposure in contrast to the adverse effect suggested by ozone-induced macrophage cytokine production.

Neutrophils

Neutrophils are recruited into the airways within 6-hours of exposure to ambient ozone50. Despite this observation, the functional importance of pulmonary neutrophils in response to ozone remains unclear. Neutrophils generate both reactive oxygen species and neutrophil elastase, which help facilitate the clearance of bacterial pathogens. Despite increased numbers of neutrophils after ozone inhalation, bacterial clearance is impaired after ozone exposure under some51 but not all conditions52. Furthermore, the role of neutrophils in the development of ozone-induced AHR remains inconsistent. Some studies support that neutrophils are required for ozone-induced AHR5355, while others do not5660. These observed discrepancies may, in part, reflect differences in the neutrophil depletion methods and the ozone exposure protocols. For example, one study demonstrated that the early AHR response to ozone is neutrophil independent, while the later response is neutrophil dependent50. Clarification of the functional role of the neutrophil after ozone inhalation is necessary.

Lymphocytes

Lymphocytes are important to both immune function and the biological response to ambient ozone. Lymphocytes are generally regarded to contribute to adaptive immunity, but can additionally contribute to the innate immune response61. Inhalation of ozone has been associated with reduced weights of lymphoid organs6264 and suppressed T-lymphocyte dependent immunologic response6566 suggesting a toxic effect of ozone on lymphocytes. Lymphocytes additionally modulate the complete response to ozone as supported by the altered response observed in animals deficient in CD4+ lymphocytes67. More recent evidence support a role of both γδ T cells and invariant natural killer T (iNKT) cells in the response to ozone. γδ T cells reside in the epithelial layer of the lung and are critical for innate host defense against pathogens and tumor cells68. γδ T cell-deficient mice exposed to ozone exhibit increased epithelial injury69 and reduced AHR70. The development of AHR in γδ T cell-deficient mice was dependent on TNF-α70. Additionally, iNKT-cells are increased after ozone inhalation and are an important source of pro-inflammatory cytokines 71. iNKT cells are required for murine ozone-induced AHR in a manner dependent on IL-1772. Together, these observations suggest that both γδ T cells and iNKT cells can contribute to the response to ozone through production of pro-inflammatory cytokines including either TNFα or IL-17. The role of specific cytokines in response to ozone is discussed in more detail later in the article. Evidence supports that lymphocytes are sensitive to the toxic effects of ozone and both γδ T cells and iNKT are important in the complete response to ozone.

GENES OF INNATE IMMUNITY AND AMBIENT OZONE

It is clear that many cell types contribute to the complete response to inhaled ozone and that a complex signaling network between cells is required. However, the extracellular factors which are either released or modified by ozone which then alter the pulmonary innate immune system remain poorly understood. We will review evidence supporting that activation of innate immunity contributes to intracellular signaling and the production of soluble pro-inflammatory factors associated with the complete response to inhaled ozone. Overall, the complete response to ozone is dependent on a complex interaction with the innate immune system.

Surfactant Protein A (SP-A)

Collectins are a class of proteins present in the airspace that contain both collagen-rich domains and lectin domains including; mannose binding lectin (MBL), surfactant protein A (SP-A), and surfactant protein D (SP-D). Collectins generally have dual innate immune functions in the airspace, either a direct function as an opsonin to facilitate clearance of foreign material/pathogens or indirectly to attenuate production of pro-inflammatory cytokines73. Both SP-A and SP-D are recognized as potent inhibitors of lipid peroxidation and oxidative cellular injury74. Previous work suggests that ozone-induced modification of lipids can act as signal transduction molecules3536. Therefore, it is not necessarily surprising that susceptibility to ozone-induced airway inflammation is associated with low levels of sp-d75 and that sp-a deficient mice are more susceptible to detrimental effects after inhalation of ozone76. While there is likely an important role for SP-D in response to ozone, the majority of recent work has focused on SP-A.

The role of SP-A in pulmonary innate immunity is diverse including; macrophage chemotaxis77, bacterial phagocytosis7882, and suppression of pro-inflammatory cytokines83. Studies in sp-a deficient animals identify a central role of SP-A in both anti-viral and anti-bacterial host defense76, 8489. sp-a deficient mice are more susceptible to ozone-induced lung injury88, 90. However, the precise mechanisms by which SP-A protects the lungs from oxidant-induced cellular injury remain unclear. Interestingly, we now recognize that in addition to the protective effects of SP-A against oxidant-induced cellular damage, the function of SP-A itself can be impaired by oxidation9193. Inhalation of ozone impairs the functional interaction between SP-A and either lung macrophages or alveolar epithelia9495. Similarly, oxidation of SP-A impairs binding to LPS and bacterial pathogens90 and hence leads to ineffective macrophage phagocytosis of bacterial pathogens76, 7980, 90. Individuals with the SP-A2 gene variant seem to be more susceptible to the effects of oxidation90. Together these findings support that SP-A can provide protection against ozone-induced lung injury. However, inhalation of ozone can itself modify SP-A function and host genetic differences in SP-A may contribute to the variation in response of individuals to inhaled ambient ozone.

Toll-like Receptor 4 (TLR4)

Toll-like receptors are a highly evolutionarily conserved family of pattern recognition receptors (PRR). The role of toll receptors in the innate immune response was initially identified in the anti-fungal host defense of the Drosophila Toll96. The mammalian homologue, tlr4, was recognized to be the exclusive bacterial LPS PRR in mice97. The original observation that tlr4 may play a role in ozone-induced lung injury was made through a forward genetic approach using the C3H/HeJ mouse98. Additionally, studies in genetically engineered tlr4-deficient mice10 identified that tlr4 contributes to ozone-induced AHR99100. We speculated that inhalation of ozone would result in release of endogenous ligands of TLR4. One such candidate was the glycosaminoglycan, hyaluronan, which is present in relatively high levels in the lung. Previous work supported that fragmented hyaluronan could be immunostimulatory to macrophages101 and could additionally function as an endogenous ligand of tlr4102. Hyaluronan fragments are important in other forms of oxidative lung injury including both bleomycin101, 103 and asbestos104. We identified that hyaluronan fragments were increased in the airspace after ozone inhalation and contribute to ozone-induced AHR47. Furthermore, ozone-induced hyaluronan fragments function as an endogenous ligand of the tlr4 induction of AHR105. Additional putative endogenous TLR-ligands are also induced by exposure to ozone. The functional consequences of many of these molecules in context of response to ozone are largely unknown. However, preliminary data suggests a potential role for hsp70 in regulation of ozone induced inflammation in a manner dependent on tlr4106. Future studies will help to further characterize these endogenous factors which activate surface receptors of pulmonary innate immunity in context of ozone exposure.

Surface ligation of the TLR4 receptor results in activation of intracellular signaling107. After inhalation of ozone, tlr4-dependent intracellular signaling is partially dependent on the intracellular adaptor molecule MyD88100. A growing body of work supports the role of NFκB-dependent signaling in the complete response to ozone108110. Ozone-induced NF-κB signaling appears important in the production of reactive nitrogen intermediates and TNF-α, thereby contributing to tissue injury111. After inhalation of ozone, there is an increased binding of the p50 subunit of NF-κB to DNA within the nucleus of both alveolar macrophages and epithelial cells. Targeted disruption of the p50 subunit of NF-κB resulted in reduced levels of peroxynitrite and protection from ozone-induced lung injury112. Additionally, nitric oxide synthase 2, (nos2), an important source of reactive nitrogen species, contributes to the response to ozone98,113 and the expression of nos2 is partially dependent on NF-κB110, 113. It is therefore, intriguing that ozone-induced expression of inducible nitric oxide synthase (iNOS) is reduced in the C3H/HeJ mouse (tlr4-mutant strain)98. This finding suggested that ligation of the surface receptor TLR4 results in NF-κB dependent gene transcription. We now know that short fragments of hyaluronan appear to drive the tlr4-dependent activation of NF-κB105.

Together these findings support that inhalation of ozone results in the release or production of endogenous ligands to TLR4, the prototypic receptor of innate immunity. Surface ligation of this receptor results in recruitment of intracellular adaptor proteins, including MyD88, required for TLR4-dependent signaling. TLR4-dependent signaling results in translocation of NF-κB to the nucleus and transcription of numerous pro-inflammatory factors associated with ozone-induced lung disease. The specific mechanisms that lead to ozone-induced AHR remain an area of considerable interest.

Tumor Necrosis Factor α

TNFα is a prototypic secreted factor released during activation of the innate immune system. The role of TNFα in response to ozone was initially identified through a genome-wide linkage analysis utilizing divergent strains of mice114. This important study supported TNFα contribution to both neutrophil recruitment into the lung and epithelial proliferation after exposure to ozone. Subsequent studies demonstrate a role of TNFα in ozone-induced AHR in mice115116. This cytokine appears to play a central role in intracellular signaling after exposure to ozone. Loss of the TNFα receptor impairs ozone-induced activation of NF-κB and MAPK/AP-1 pathways, which are each important to the complete biological response to ozone117. The functional role of TNFα in the human response to ozone remains unknown but is suggested as a common variant of TNFα was associated with response to ozone in human subjects118. Collectively, these data further support the role of innate immune activation in the response to ozone. Clear understanding of the mechanisms, by which, TNFα modifies the complete response to ozone in both animal models and human subjects will provide considerable insight into the pathogenesis of ozone-induced airways disease.

Interleukin-1

IL-1 is a pro-inflammatory cytokine that contributes to both acute and chronic inflammation. There are three members of the IL-1 gene family, IL-1α, IL-1β, and IL-1 receptor antagonist (IL-1Ra). The available evidence supports a role for IL-1 signaling both in the development of ozone induced lung injury and also ozone induced AHR. IL-1β appears to have a central role in the development of inflammatory responses. IL-1β is primarily derived from cells of a monocytic lineage119 and is released by macrophages after direct exposure to ozone42. IL-1β is recognized to increase both cyclooxygenase (COX)-2 expression and prostaglandin E2 resulting in decreased β-adrenergic responsiveness of smooth muscle cells providing a potential link to AHR120. Administration of an IL-1 receptor antagonist protected mice against ozone-induced AHR, cellular inflammation, epithelial injury, production of several pro-inflammatory cytokines, and ozone-enhanced airway smooth muscle responses121122. The specific disruption of the type 1 IL-1 receptor attenuated ozone-induced AHR123124. Collectively, these findings support a central role of IL-1 dependent signaling in response to ozone.

Interleukin-6

The pleiotropic cytokine, IL-6, is reported to have either pro-inflammatory or anti-inflammatory effects depending on the context125126. In the lungs, transgenic over-expression of IL-6 in the absence of any exposure results in a decrease in airway hyper-responsiveness 127, which appears related to airway structural changes128. After inhalation of ozone, IL-6 is released into the airspace129131 and is synthesized by both macrophages and epithelial cells27, 42. In context of ozone inhalation, IL-6 appears to contribute to airway epithelial injury132, recruitment of neutrophils into the airspace, and expression of TNFα50. These findings support that IL-6 contributes to ozone-induced lung inflammation and epithelial injury, but not AHR.

KC

KC, the mouse counterpart to human IL-8, is a member of the family of chemotactic cytokines (chemokines). KC it is thought to play a role in the recruitment and activation of leukocytes during inflammatory responses. KC expression in the lung can be induced by either TNFα133 or exposure to ozone122. Interestingly, ozone-induced expression of KC is dependent on TLR4, TLR2, and MyD88100. Only indirect evidence suggests that KC contribute to the response to ozone. Previous work supports that CXCR2, the receptor for KC and MIP2, is required for PMN recruitment and AHR after exposure to ozone50.

Interleukin 17

IL-17 is pro-inflammatory cytokine commonly associated with allergic responses and induction of many other cytokines (including; IL-6, IL-1β, TNFα)134. IL-17 has been found to play a role in the biological response to ozone. It was demonstrated that the number of IL-17 producing iNKT cells in the lung is increased after ozone exposure and ozone-induced AHR is dependent on both IL-17 and iNKT cells72.

Complement

Complement activation is another highly evolutionarily conserved component of the innate immune system. Human exposure to ozone resulted in an increased level of C3a in BAL fluid135. Depletion of complement during ozone challenge attenuates both neutrophil recruitment into the lung, pro-inflammatory cytokine production, and AHR58. Interestingly, the effect of complement on AHR was independent of neutrophil recruitment into the airspace58. While we recognize that both C3a and C5a can activate mast cells136,137, the effect with ozone appears to be independent of mast cells58, 138. The mechanisms and cell types affected by complement after exposure to ozone remain largely unknown.

OZONE PRIMES PULMONARY INNATE IMMUNITY

We have focused on the importance of genes of innate immunity in the biological response to ozone. However, recent evidence support that inhalation of ozone can additionally modify subsequent innate immune response to microbial pathogens. This is particularly important because we typically encounter pathogens in context of multiple inhaled toxicants. Effective clearance of microbial pathogens requires both recognition of foreign antigens and a controlled inflammatory response. Exaggerated initial responses to pathogens can result in enhanced lung injury and adverse clinical outcomes. Thus, a considerable interest exists to understand the complex interplay between commonly encountered inhaled environmental toxins and the pulmonary innate immune system.

Inhalation of ozone can directly impair antibacterial clearance and pathogen killing. Previous studies demonstrate that inhalation of ozone can impair clearance of multiple pathogens including; Staphylococcus aureus139, Streptococcus pyogenes140, Streptococcus zooepidemicus41, Klebsiella pneumonia141, Mycobacterium tuberculosis142, and Listeria monocytogenes66. Altered vulnerability to these bacterial pathogens suggests that ambient ozone could directly modify innate immune function in the lung. Clear understanding of the mechanisms, by which, ozone modifies antibacterial host defense could provide insight into the mechanisms which regulate the enhanced morbidity and mortality observed in human populations after exposure to higher ambient ozone concentrations.

Previously we outlined that ozone modifies alveolar macrophage function by impairing phagocytosis, superoxide production, and increasing levels of secreted pro-inflammatory cytokine production45, 143. However, pre-exposure to ozone can enhance the subsequent biological response to inhaled LPS including; increased cytokine production, increased lung injury, and increased airway hyperresponsiveness. Seemingly a paradox, pre-exposure to ozone resulted in a reduced number of macrophages in the lungs. However, consistent with the other phenotypes, pre-exposure to ozone enhanced LPS response, which was manifested as an increase in macrophage apoptosis144. Fewer functional macrophages and enhanced lung injury would be anticipated to be associated with impaired microbial pathogen clearance. The enhanced response of macrophages to LPS after ozone exposure resulted from ozone-induced trafficking of TLR4 to the surface of alveolar macrophages144. We now recognize that inhalation of ozone results in fragmentation of hyaluronan47 and these fragments of hyaluronan contribute to the increased macrophage surface expression of TLR4 and enhanced functional response to LPS145.

TLR4-dependent signaling in the lung appears to be a double-edged sword. A controlled response appears to be critical for effective clearance of bacterial pathogens, but an exaggerated response can be associated with an increase in AHR, airway injury, and reduced numbers of functional inflammatory cells. Understanding the fundamental homeostatic mechanisms regulating pulmonary innate immunity and the complex relationship with common environmental exposures will inevitably help us gain a better understanding of the etiology and pathogenesis of inflammatory airways disease.

INHALATION OF OZONE CAN MODIFY ADAPTIVE IMMUNITY

Asthma affects a total of 300 million worldwide contributes to an estimated 250,000 deaths per year. In the USA, approximately 10% of the population is asthmatic and approximately 4,000 deaths per year are attributed to asthma146147. The increased prevalence of asthma in urban environments with high ozone levels, suggests that ozone may contribute to the pathogenesis of asthma. The overall effects of ambient ozone on allergic airways disease appears variable and depends on the timing, dose, and duration of exposure in both rodents148151 and humans152153. Ozone appears to have a dual effect of both exacerbating existing disease as well as to function as an adjuvant facilitating sensitization to potential allergens. Therefore, it is likely that high levels of ambient ozone contribute to both the severity and prevalence of allergic airways disease in urban environments.

Evidence from both animal models and humans with pre-existing asthma support the concept that inhalation of ozone contributes to exacerbation of allergic airways disease154. Numerous studies utilizing animal models of allergic airways disease support that secondary challenge to ozone results in enhanced inflammation, airway injury, and AHR. Some evidence support that ozone can suppress Th1 response and favor Th2 reactions155156. Similarly numerous controlled ozone exposure studies in humans with pre-existing asthma demonstrate an exacerbation of asthma-related phenotypes. These findings are further supported by epidemiological studies which consistently demonstrate exacerbations in pre-existing asthma related to ambient levels of ozone157.

The mechanisms that ozone contributes to exacerbations of pre-existing asthma are an area of considerable interest. Controlled human exposure studies with asthmatic subjects demonstrate increased numbers of neutrophils, monocytes, and mast cells in the airspace after inhalation of ozone. Additionally, inhalation of ozone increased the levels of allergen-specific antibodies, the number of antigen presenting cells in the lung, and the expression of both MHC II and co-stimulatory molecules (B7.1, B7.2, CD11b or CD11c) necessary for antigen presentation158162. Recent evidence from ozone exposed human asthmatics suggests that one mechanism of exacerbated disease is through modification of the innate immune response163. It is well known that generalized activation of innate immunity can exacerbate existing allergic airways disease164169. Not only does human inhalation of ozone increase surface markers associated with antigen presentation (CD86, HLA-DR), but ozone additionally can induce monocyte expression of cell surface molecules associated with innate immunity (mCD14, CD11b, CD16)163, 170. These data suggest that ozone-induced priming of innate immunity may contribute to exacerbations of pre-existing asthma. The current evidence supports that ozone can exacerbate pre-existing asthma through enhanced cellular inflammation, more efficient DC-T cell interactions, and likely through priming monocyte-derived innate immunity.

Considerable evidence from animal studies support that exposure to ozone can also enhance sensitization to antigen in the lung. Ozone exposure has been shown to enhance sensitization to OVA in divergent strains of mice171. When rodents are co-exposed to OVA aerosol and ozone, then subsequently challenged to systemic OVA, there was a significant increase in the level of sensitization as supported by enhanced antigen-dependent fatal shock172173 and increased IgE-containing cells in the lung174. In monkeys, ozone exposure enhances the development of allergy to both house dust mite allergen175 and inhaled platinum176. Cumulatively, these data support that ambient ozone promotes airway sensitization to airborne allergens through a previously unrecognized mechanism.

We now know that genes of innate immunity can activate adaptive immunity177 and contribute to airway sensitization to some antigens. For example, LPS can act as an adjuvant in a model of airway sensitization to ovalbumin in a manner dependent on TLR4165. Similarly, we have recently reported that ozone can function as a weak adjuvant during airway sensitization to ovalbumin in a manner dependent on TLR4178. These observations suggest that inhalation of ozone may additionally facilitate sensitization to otherwise inert antigens. There are currently no human data to support the potential role of ozone in sensitization to allergic antigens. If these observations are validated, this mechanism could partially account for the increased prevalence of allergic disease observed in urban environments.

Ozone impacts the pathogenesis of allergic airways disease. Ambient ozone can contribute to exacerbations of pre-existing asthma. Animal studies suggest that ozone can additionally function as a weak adjuvant during airway exposure to antigen. Interestingly, it appears that the innate immune system is important in both ozone-induced exacerbations of asthma and airway sensitization to antigens. Future studies in both animal models and humans are necessary to help clarify the complex interaction between ozone, allergic asthma, and the innate immune system.

CONCLUSIONS

Ambient ozone is a ubiquitous urban pollutant recognized to have adverse health effects. From a public health perspective, it is anticipated that climate change will increase the global burden of ground level ozone and further contribute to adverse health outcomes. Therefore, while ozone provides an environmentally relevant model of non-infectious lung injury to understand the pathogenesis of lung disease, improved understanding of the biological response to ozone could additionally improve future therapeutic approaches to non-allergic and allergic airways disease.

Current evidence supports a complex interaction between inhalation of environmental ozone and the pulmonary innate immune system. Inhalation of ozone can alter many cell types in the lung required for intact immediate host defense. The biological response to ozone is dependent on genes of innate immunity including; surface receptors, intracellular signaling molecules, and the production of downstream pro-inflammatory cytokines. Interestingly, inhalation of ozone can additionally prime innate immune response through inducing trafficking of tlr4 to the surface of macrophages. Given the role of innate immunity in subsequent adaptive immune response, it is perhaps not surprising that ozone can interact with adaptive immune response through activation of innate immunity. Understanding the mechanisms that regulate the response to ozone can provide fundamental insight into gene x environment interactions and will broadly impact our understanding of inflammatory lung disease.

Many challenges remain to understand the biological response to ozone. Quite large gaps remain in our current understanding of the complex interaction between inhalation of ozone and innate immunity. The specific genes of innate immunity and cell types required for the complete biological response to ozone remain unknown. We have a very limited understanding of the complex signaling networks between cell types required for the response to ozone. It remains unknown whether inhalation of ozone modifies the response to toll-like receptor ligands other than those to tlr4. The specific innate immune mechanisms required for ozone to modify adaptive immunity remain unknown. Finally, there is only limited evidence supporting that mechanisms required for the response to ozone in animal models are relevant to human disease. Mechanistic studies in human cohorts are required to translate observations from animal models.

Overall, studies of ambient ozone have provided novel insight into the pathogenesis of airways disease. Investigations of non-infectious lung injury associated with ozone have provided fundamental insight into mechanisms that a common inhaled environmental exposure can interact with the host innate immune system. Observations from this line of investigation could lead to the development of new approaches to therapy for many individuals suffering from inflammatory airways disease.

Acknowledgments

The authors appreciate financial support from the NIH (ES016126, ES016659).

References

  • 1.Katsouyanni K, Zmirou D, Spix C, et al. Short-term effects of air pollution on health: a European approach using epidemiological time-series data. The APHEA project: background, objectives, design. Eur Respir J. 1995 Jun;8(6):1030–1038. [PubMed] [Google Scholar]
  • 2.Gryparis A, Forsberg B, Katsouyanni K, et al. Acute effects of ozone on mortality from the “air pollution and health: a European approach” project. Am J Respir Crit Care Med. 2004 Nov 15;170(10):1080–1087. doi: 10.1164/rccm.200403-333OC. [DOI] [PubMed] [Google Scholar]
  • 3.Ito K, De Leon SF, Lippmann M. Associations between ozone and daily mortality: analysis and meta-analysis. Epidemiology. 2005 Jul;16(4):446–457. doi: 10.1097/01.ede.0000165821.90114.7f. [DOI] [PubMed] [Google Scholar]
  • 4.Levy JI, Chemerynski SM, Sarnat JA. Ozone exposure and mortality: an empiric bayes metaregression analysis. Epidemiology. 2005 Jul;16(4):458–468. doi: 10.1097/01.ede.0000165820.08301.b3. [DOI] [PubMed] [Google Scholar]
  • 5.Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987–2000. JAMA. 2004 Nov 17;292(19):2372–2378. doi: 10.1001/jama.292.19.2372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Liao H, Chen W-T, Seinfeld JH. Role of climate change in global predictions of future tropospheric ozone and aerosols. J Geophys Res. 2006;111(D12):1–18. [Google Scholar]
  • 7.Murazaki K, Hess P. How does climate change contribute to surface ozone change over the United States? J Geophys Res. 2006;111(D5):1–16. [Google Scholar]
  • 8.Morris GE, Parker LC, Ward JR, et al. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J. 2006 Oct;20(12):2153–2155. doi: 10.1096/fj.06-5910fje. [DOI] [PubMed] [Google Scholar]
  • 9.Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002 Jan 15;168(2):554–561. doi: 10.4049/jimmunol.168.2.554. [DOI] [PubMed] [Google Scholar]
  • 10.Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999 Apr 1;162(7):3749–3752. [PubMed] [Google Scholar]
  • 11.Malcolm KC, Arndt PG, Manos EJ, Jones DA, Worthen GS. Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol. 2003 Apr;284(4):L663–670. doi: 10.1152/ajplung.00094.2002. [DOI] [PubMed] [Google Scholar]
  • 12.Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol. 2003 May 1;170(9):4665–4672. doi: 10.4049/jimmunol.170.9.4665. [DOI] [PubMed] [Google Scholar]
  • 13.Weighardt H, Jusek G, Mages J, et al. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur J Immunol. 2004 Feb;34(2):558–564. doi: 10.1002/eji.200324714. [DOI] [PubMed] [Google Scholar]
  • 14.Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol. 2004 Sep;31(3):358–364. doi: 10.1165/rcmb.2003-0388OC. [DOI] [PubMed] [Google Scholar]
  • 15.Guillot L, Medjane S, Le-Barillec K, et al. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem. 2004 Jan 23;279(4):2712–2718. doi: 10.1074/jbc.M305790200. [DOI] [PubMed] [Google Scholar]
  • 16.Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000 Jun;25(2):187–191. doi: 10.1038/76048. [DOI] [PubMed] [Google Scholar]
  • 17.Andonegui G, Bonder CS, Green F, et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest. 2003 Apr;111(7):1011–1020. doi: 10.1172/JCI16510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stephens RJ, Evans MJ, Sloan MF, Freeman G. A comprehensive ultrastructural study of pulmonary injury and repair in the rat resulting from exposures to less than one PPM ozone. Chest. 1974 Apr;65(Suppl):11S–13S. doi: 10.1378/chest.65.4_supplement.11s. [DOI] [PubMed] [Google Scholar]
  • 19.Foster WM, Stetkiewicz PT. Regional clearance of solute from the respiratory epithelia: 18–20 h postexposure to ozone. J Appl Physiol. 1996 Sep;81(3):1143–1149. doi: 10.1152/jappl.1996.81.3.1143. [DOI] [PubMed] [Google Scholar]
  • 20.Kehrl HR, Vincent LM, Kowalsky RJ, et al. Ozone exposure increases respiratory epithelial permeability in humans. Am Rev Respir Dis. 1987 May;135(5):1124–1128. doi: 10.1164/arrd.1987.135.5.1124. [DOI] [PubMed] [Google Scholar]
  • 21.Foster WM, Costa DL, Langenback EG. Ozone exposure alters tracheobronchial mucociliary function in humans. J Appl Physiol. 1987 Sep;63(3):996–1002. doi: 10.1152/jappl.1987.63.3.996. [DOI] [PubMed] [Google Scholar]
  • 22.Hippenstiel S, Opitz B, Schmeck B, Suttorp N. Lung epithelium as a sentinel and effector system in pneumonia--molecular mechanisms of pathogen recognition and signal transduction. Respir Res. 2006;7:97. doi: 10.1186/1465-9921-7-97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev. 2000 Feb;173:27–38. doi: 10.1034/j.1600-065x.2000.917304.x. [DOI] [PubMed] [Google Scholar]
  • 24.Gribar SC, Richardson WM, Sodhi CP, Hackam DJ. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med. 2008 Sep-Oct;14(9–10):645–659. doi: 10.2119/2008-00035.Gribar. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mayer AK, Dalpke AH. Regulation of local immunity by airway epithelial cells. Arch Immunol Ther Exp (Warsz) 2007 Nov-Dec;55(6):353–362. doi: 10.1007/s00005-007-0041-7. [DOI] [PubMed] [Google Scholar]
  • 26.Devlin RB, McDonnell WF, Mann R, et al. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol. 1991 Jan;4(1):72–81. doi: 10.1165/ajrcmb/4.1.72. [DOI] [PubMed] [Google Scholar]
  • 27.Devlin RB, McKinnon KP, Noah T, Becker S, Koren HS. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am J Physiol. 1994 Jun;266(6 Pt 1):L612–619. doi: 10.1152/ajplung.1994.266.6.L612. [DOI] [PubMed] [Google Scholar]
  • 28.Nichols BG, Woods JS, Luchtel DL, Corral J, Koenig JQ. Effects of ozone exposure on nuclear factor-kappaB activation and tumor necrosis factor-alpha expression in human nasal epithelial cells. Toxicol Sci. 2001 Apr;60(2):356–362. doi: 10.1093/toxsci/60.2.356. [DOI] [PubMed] [Google Scholar]
  • 29.Rusznak C, Devalia JL, Sapsford RJ, Davies RJ. Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur Respir J. 1996 Nov;9(11):2298–2305. doi: 10.1183/09031936.96.09112298. [DOI] [PubMed] [Google Scholar]
  • 30.Jaspers I, Chen LC, Flescher E. Induction of interleukin-8 by ozone is mediated by tyrosine kinase and protein kinase A, but not by protein kinase C. J Cell Physiol. 1998 Nov;177(2):313–323. doi: 10.1002/(SICI)1097-4652(199811)177:2<313::AID-JCP13>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  • 31.Voynow JA, Fischer BM, Zheng S, et al. NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans. Am J Respir Cell Mol Biol. 2009 Jul;41(1):107–113. doi: 10.1165/rcmb.2008-0381OC. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  • 32.Wang J, Wang S, Manzer R, McConville G, Mason RJ. Ozone induces oxidative stress in rat alveolar type II and type I-like cells. Free Radic Biol Med. 2006 Jun 1;40(11):1914–1928. doi: 10.1016/j.freeradbiomed.2006.01.017. [DOI] [PubMed] [Google Scholar]
  • 33.Manzer R, Wang J, Nishina K, McConville G, Mason RJ. Alveolar epithelial cells secrete chemokines in response to IL-1beta and lipopolysaccharide but not to ozone. Am J Respir Cell Mol Biol. 2006 Feb;34(2):158–166. doi: 10.1165/rcmb.2005-0205OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Pryor WA. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic Biol Med. 1992;12(1):83–88. doi: 10.1016/0891-5849(92)90060-t. [DOI] [PubMed] [Google Scholar]
  • 35.Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med. 1995 Dec;19(6):935–941. doi: 10.1016/0891-5849(95)02033-7. [DOI] [PubMed] [Google Scholar]
  • 36.Leikauf GD, Zhao Q, Zhou S, Santrock J. Activation of eicosanoid metabolism in human airway epithelial cells by ozonolysis products of membrane fatty acids. Res Rep Health Eff Inst. 1995 Sep;(71):1–15. discussion 19–26. [PubMed] [Google Scholar]
  • 37.Manzer R, Dinarello CA, McConville G, Mason RJ. Ozone exposure of macrophages induces an alveolar epithelial chemokine response through IL-1alpha. Am J Respir Cell Mol Biol. 2008 Mar;38(3):318–323. doi: 10.1165/rcmb.2007-0250OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Janic B, Umstead TM, Phelps DS, Floros J. An in vitro cell model system for the study of the effects of ozone and other gaseous agents on phagocytic cells. J Immunol Methods. 2003 Jan 15;272(1–2):125–134. doi: 10.1016/s0022-1759(02)00440-4. [DOI] [PubMed] [Google Scholar]
  • 39.Becker S, Quay J, Koren HS. Effect of ozone on immunoglobulin production by human B cells in vitro. J Toxicol Environ Health. 1991 Nov;34(3):353–366. doi: 10.1080/15287399109531573. [DOI] [PubMed] [Google Scholar]
  • 40.Gilmour MI, Hmieleski RR, Stafford EA, Jakab GJ. Suppression and recovery of the alveolar macrophage phagocytic system during continuous exposure to 0.5 ppm ozone. Exp Lung Res. 1991 May-Jun;17(3):547–558. doi: 10.3109/01902149109062864. [DOI] [PubMed] [Google Scholar]
  • 41.Gilmour MI, Park P, Selgrade MK. Ozone-enhanced pulmonary infection with Streptococcus zooepidemicus in mice. The role of alveolar macrophage function and capsular virulence factors. Am Rev Respir Dis. 1993 Mar;147(3):753–760. doi: 10.1164/ajrccm/147.3.753. [DOI] [PubMed] [Google Scholar]
  • 42.Arsalane K, Gosset P, Vanhee D, et al. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am J Respir Cell Mol Biol. 1995 Jul;13(1):60–68. doi: 10.1165/ajrcmb.13.1.7598938. [DOI] [PubMed] [Google Scholar]
  • 43.Ishii Y, Yang H, Sakamoto T, et al. Rat alveolar macrophage cytokine production and regulation of neutrophil recruitment following acute ozone exposure. Toxicol Appl Pharmacol. 1997 Dec;147(2):214–223. doi: 10.1006/taap.1997.8275. [DOI] [PubMed] [Google Scholar]
  • 44.Larini A, Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol In Vitro. 2005 Feb;19(1):55–61. doi: 10.1016/j.tiv.2004.06.007. [DOI] [PubMed] [Google Scholar]
  • 45.Becker S, Madden MC, Newman SL, Devlin RB, Koren HS. Modulation of human alveolar macrophage properties by ozone exposure in vitro. Toxicol Appl Pharmacol. 1991 Sep 15;110(3):403–415. doi: 10.1016/0041-008x(91)90042-d. [DOI] [PubMed] [Google Scholar]
  • 46.Janic B, Umstead TM, Phelps DS, Floros J. Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation. Am J Physiol Lung Cell Mol Physiol. 2005 Feb;288(2):L317–325. doi: 10.1152/ajplung.00125.2004. [DOI] [PubMed] [Google Scholar]
  • 47.Garantziotis S, Li Z, Potts EN, et al. Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem. 2009 Apr 24;284(17):11309–11317. doi: 10.1074/jbc.M802400200. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  • 48.Dahl M, Bauer AK, Arredouani M, et al. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest. 2007 Mar;117(3):757–764. doi: 10.1172/JCI29968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pulfer MK, Murphy RC. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J Biol Chem. 2004 Jun 18;279(25):26331–26338. doi: 10.1074/jbc.M403581200. [DOI] [PubMed] [Google Scholar]
  • 50.Johnston RA, Mizgerd JP, Shore SA. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L61–67. doi: 10.1152/ajplung.00101.2004. [DOI] [PubMed] [Google Scholar]
  • 51.Peterson ML, Harder S, Rummo N, House D. Effect of ozone on leukocyte function in exposed human subjects. Environ Res. 1978 Jun;15(3):485–493. doi: 10.1016/0013-9351(78)90127-5. [DOI] [PubMed] [Google Scholar]
  • 52.Margalit M, Attias E, Attias D, Elstein D, Zimran A, Matzner Y. Effect of ozone on neutrophil function in vitro. Clin Lab Haematol. 2001 Aug;23(4):243–247. doi: 10.1046/j.1365-2257.2001.00401.x. [DOI] [PubMed] [Google Scholar]
  • 53.DeLorme MP, Yang H, Elbon-Copp C, Gao X, Barraclough-Mitchell H, Bassett DJ. Hyperresponsive airways correlate with lung tissue inflammatory cell changes in ozone-exposed rats. J Toxicol Environ Health A. 2002 Oct 11;65(19):1453–1470. doi: 10.1080/00984100290071432. [DOI] [PubMed] [Google Scholar]
  • 54.Holtzman MJ, Fabbri LM, O’Byrne PM, et al. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis. 1983 Jun;127(6):686–690. doi: 10.1164/arrd.1983.127.6.686. [DOI] [PubMed] [Google Scholar]
  • 55.O’Byrne PM, Walters EH, Gold BD, et al. Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. Am Rev Respir Dis. 1984 Aug;130(2):214–219. doi: 10.1164/arrd.1984.130.2.214. [DOI] [PubMed] [Google Scholar]
  • 56.Evans TW, Brokaw JJ, Chung KF, Nadel JA, McDonald DM. Ozone-induced bronchial hyperresponsiveness in the rat is not accompanied by neutrophil influx or increased vascular permeability in the trachea. Am Rev Respir Dis. 1988 Jul;138(1):140–144. doi: 10.1164/ajrccm/138.1.140. [DOI] [PubMed] [Google Scholar]
  • 57.Koto H, Salmon M, Haddad el B, Huang TJ, Zagorski J, Chung KF. Role of cytokine-induced neutrophil chemoattractant (CINC) in ozone-induced airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med. 1997 Jul;156(1):234–239. doi: 10.1164/ajrccm.156.1.9606095. [DOI] [PubMed] [Google Scholar]
  • 58.Park JW, Taube C, Joetham A, et al. Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med. 2004 Mar 15;169(6):726–732. doi: 10.1164/rccm.200307-1042OC. [DOI] [PubMed] [Google Scholar]
  • 59.Zhang LY, Levitt RC, Kleeberger SR. Differential susceptibility to ozone-induced airways hyperreactivity in inbred strains of mice. Exp Lung Res. 1995 Jul-Aug;21(4):503–518. doi: 10.3109/01902149509031755. [DOI] [PubMed] [Google Scholar]
  • 60.Pino MV, Stovall MY, Levin JR, Devlin RB, Koren HS, Hyde DM. Acute ozone-induced lung injury in neutrophil-depleted rats. Toxicol Appl Pharmacol. 1992 Jun;114(2):268–276. doi: 10.1016/0041-008x(92)90077-6. [DOI] [PubMed] [Google Scholar]
  • 61.Gonzalez-Navajas JM, Fine S, Law J, et al. TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J Clin Invest. 2010 Feb 1;120(2):570–581. doi: 10.1172/JCI40055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Fujimaki H, Ozawa M, Imai T, Shimizu F. Effect of short-term exposure to O3 on antibody response in mice. Environ Res. 1984 Dec;35(2):490–496. doi: 10.1016/0013-9351(84)90155-5. [DOI] [PubMed] [Google Scholar]
  • 63.Dziedzic D, White HJ. Thymus and pulmonary lymph node response to acute and subchronic ozone inhalation in the mouse. Environ Res. 1986 Dec;41(2):598–609. doi: 10.1016/s0013-9351(86)80154-2. [DOI] [PubMed] [Google Scholar]
  • 64.Dziedzic D, White HJ. T-cell activation in pulmonary lymph nodes of mice exposed to ozone. Environ Res. 1986 Dec;41(2):610–622. doi: 10.1016/s0013-9351(86)80155-4. [DOI] [PubMed] [Google Scholar]
  • 65.Fujimaki H, Shiraishi F, Ashikawa T, Murakami M. Changes in delayed hypersensitivity reaction in mice exposed to O3. Environ Res. 1987 Jun;43(1):186–190. doi: 10.1016/s0013-9351(87)80070-1. [DOI] [PubMed] [Google Scholar]
  • 66.Van Loveren H, Rombout PJ, Wagenaar SS, Walvoort HC, Vos JG. Effects of ozone on the defense to a respiratory Listeria monocytogenes infection in the rat. Suppression of macrophage function and cellular immunity and aggravation of histopathology in lung and liver during infection. Toxicol Appl Pharmacol. 1988 Jul;94(3):374–393. doi: 10.1016/0041-008x(88)90279-7. [DOI] [PubMed] [Google Scholar]
  • 67.Chen X, Gavett SH, Wills-Karp M. CD4+ T lymphocyte modulation of ozone-induced murine pulmonary inflammation. Am J Respir Cell Mol Biol. 1995 Apr;12(4):396–403. doi: 10.1165/ajrcmb.12.4.7695918. [DOI] [PubMed] [Google Scholar]
  • 68.Komori HK, Meehan TF, Havran WL. Epithelial and mucosal gamma delta T cells. Curr Opin Immunol. 2006 Oct;18(5):534–538. doi: 10.1016/j.coi.2006.06.001. [DOI] [PubMed] [Google Scholar]
  • 69.King DP, Hyde DM, Jackson KA, et al. Cutting edge: protective response to pulmonary injury requires gamma delta T lymphocytes. J Immunol. 1999 May 1;162(9):5033–5036. [PubMed] [Google Scholar]
  • 70.Matsubara S, Takeda K, Jin N, et al. Vgamma1+ T cells and tumor necrosis factor-alpha in ozone-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2009 Apr;40(4):454–463. doi: 10.1165/rcmb.2008-0346OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;23:877–900. doi: 10.1146/annurev.immunol.23.021704.115742. [DOI] [PubMed] [Google Scholar]
  • 72.Pichavant M, Goya S, Meyer EH, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med. 2008 Feb 18;205(2):385–393. doi: 10.1084/jem.20071507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005 Jan;5(1):58–68. doi: 10.1038/nri1528. [DOI] [PubMed] [Google Scholar]
  • 74.Bridges JP, Davis HW, Damodarasamy M, et al. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem. 2000 Dec 8;275(49):38848–38855. doi: 10.1074/jbc.M005322200. [DOI] [PubMed] [Google Scholar]
  • 75.Kierstein S, Poulain FR, Cao Y, et al. Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respir Res. 2006;7:85. doi: 10.1186/1465-9921-7-85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Mikerov AN, Haque R, Gan X, Guo X, Phelps DS, Floros J. Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences. Respir Res. 2008;9:77. doi: 10.1186/1465-9921-9-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Zhu S, Kachel DL, Martin WJ, 2nd, Matalon S. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages. Am J Physiol. 1998 Dec;275(6 Pt 1):L1031–1039. doi: 10.1152/ajplung.1998.275.6.L1031. [DOI] [PubMed] [Google Scholar]
  • 78.Ding J, Umstead TM, Floros J, Phelps DS. Factors affecting SP-A-mediated phagocytosis in human monocytic cell lines. Respir Med. 2004 Jul;98(7):637–650. doi: 10.1016/j.rmed.2003.12.018. [DOI] [PubMed] [Google Scholar]
  • 79.Mikerov AN, Wang G, Umstead TM, et al. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun. 2007 Mar;75(3):1403–1412. doi: 10.1128/IAI.01341-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Mikerov AN, Umstead TM, Huang W, Liu W, Phelps DS, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L150–158. doi: 10.1152/ajplung.00135.2004. [DOI] [PubMed] [Google Scholar]
  • 81.Khubchandani KR, Goss KL, Engelhardt JF, Snyder JM. In situ hybridization of SP-A mRNA in adult human conducting airways. Pediatr Pathol Mol Med. 2001 Sep-Oct;20(5):349–366. [PubMed] [Google Scholar]
  • 82.Khubchandani KR, Snyder JM. Surfactant protein A (SP-A): the alveolus and beyond. FASEB J. 2001 Jan;15(1):59–69. doi: 10.1096/fj.00-0318rev. [DOI] [PubMed] [Google Scholar]
  • 83.Wang G, Phelps DS, Umstead TM, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol. 2000 May;278(5):L946–954. doi: 10.1152/ajplung.2000.278.5.L946. [DOI] [PubMed] [Google Scholar]
  • 84.LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest. 1999 Apr;103(7):1015–1021. doi: 10.1172/JCI5849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 1998 Oct;19(4):700–708. doi: 10.1165/ajrcmb.19.4.3254. [DOI] [PubMed] [Google Scholar]
  • 86.LeVine AM, Kurak KE, Wright JR, et al. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol. 1999 Feb;20(2):279–286. doi: 10.1165/ajrcmb.20.2.3303. [DOI] [PubMed] [Google Scholar]
  • 87.LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol. 2001 Nov 15;167(10):5868–5873. doi: 10.4049/jimmunol.167.10.5868. [DOI] [PubMed] [Google Scholar]
  • 88.Haque R, Umstead TM, Ponnuru P, et al. Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice. Toxicol Appl Pharmacol. 2007 Apr 1;220(1):72–82. doi: 10.1016/j.taap.2006.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Peel JL, Metzger KB, Klein M, Flanders WD, Mulholland JA, Tolbert PE. Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups. Am J Epidemiol. 2007 Mar 15;165(6):625–633. doi: 10.1093/aje/kwk051. [DOI] [PubMed] [Google Scholar]
  • 90.Mikerov AN, Umstead TM, Gan X, et al. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol. 2008 Jan;294(1):L121–130. doi: 10.1152/ajplung.00288.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production. Environ Health Perspect. 2002 Jan;110(1):79–84. doi: 10.1289/ehp.0211079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Mikerov AN, Gan X, Umstead TM, et al. Sex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infection. Respir Res. 2008;9:24. doi: 10.1186/1465-9921-9-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Stagos D, Umstead TM, Phelps DS, et al. Inhibition of ozone-induced SP-A oxidation by plant polyphenols. Free Radic Res. 2007 Mar;41(3):357–366. doi: 10.1080/10715760601064714. [DOI] [PubMed] [Google Scholar]
  • 94.Oosting RS, Van Iwaarden JF, Van Bree L, Verhoef J, Van Golde LM, Haagsman HP. Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells. Am J Physiol. 1992 Jan;262(1 Pt 1):L63–68. doi: 10.1152/ajplung.1992.262.1.L63. [DOI] [PubMed] [Google Scholar]
  • 95.Oosting RS, van Greevenbroek MM, Verhoef J, van Golde LM, Haagsman HP. Structural and functional changes of surfactant protein A induced by ozone. Am J Physiol. 1991 Aug;261(2 Pt 1):L77–83. doi: 10.1152/ajplung.1991.261.2.L77. [DOI] [PubMed] [Google Scholar]
  • 96.Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996 Sep 20;86(6):973–983. doi: 10.1016/s0092-8674(00)80172-5. [DOI] [PubMed] [Google Scholar]
  • 97.Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998 Dec 11;282(5396):2085–2088. doi: 10.1126/science.282.5396.2085. [DOI] [PubMed] [Google Scholar]
  • 98.Kleeberger SR, Reddy SP, Zhang LY, Cho HY, Jedlicka AE. Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol. 2001 Feb;280(2):L326–333. doi: 10.1152/ajplung.2001.280.2.L326. [DOI] [PubMed] [Google Scholar]
  • 99.Hollingsworth JW, 2nd, Cook DN, Brass DM, et al. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med. 2004 Jul 15;170(2):126–132. doi: 10.1164/rccm.200311-1499OC. [DOI] [PubMed] [Google Scholar]
  • 100.Williams AS, Leung SY, Nath P, et al. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol. 2007 Oct;103(4):1189–1195. doi: 10.1152/japplphysiol.00172.2007. [DOI] [PubMed] [Google Scholar]
  • 101.Noble PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med. 1996 May 1;183(5):2373–2378. doi: 10.1084/jem.183.5.2373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem. 2004 Apr 23;279(17):17079–17084. doi: 10.1074/jbc.M310859200. [DOI] [PubMed] [Google Scholar]
  • 103.Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005 Nov;11(11):1173–1179. doi: 10.1038/nm1315. [DOI] [PubMed] [Google Scholar]
  • 104.Gao F, Koenitzer JR, Tobolewski JM, et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem. 2008 Mar 7;283(10):6058–6066. doi: 10.1074/jbc.M709273200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Garantziotis S, Li Z, Potts EN, et al. TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med. 2010 Apr 1;181(7):666–675. doi: 10.1164/rccm.200903-0381OC. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  • 106.Bauer AK, Travis EL, Malhotra SS, et al. Identification of novel susceptibility genes in ozone-induced inflammation in mice. Eur Respir J. 2009 Dec 23; doi: 10.1183/09031936.00145309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010 May;11(5):373–384. doi: 10.1038/ni.1863. [DOI] [PubMed] [Google Scholar]
  • 108.Chung KF, Adcock IM. Induction of nuclear factor-kappa B by exposure to ozone and inhibition by glucocorticoids. Methods Enzymol. 2000;319:551–562. doi: 10.1016/s0076-6879(00)19052-4. [DOI] [PubMed] [Google Scholar]
  • 109.Punjabi CJ, Laskin JD, Pendino KJ, Goller NL, Durham SK, Laskin DL. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol. 1994 Aug;11(2):165–172. doi: 10.1165/ajrcmb.11.2.7519435. [DOI] [PubMed] [Google Scholar]
  • 110.Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994 Feb 18;269(7):4705–4708. [PubMed] [Google Scholar]
  • 111.Fakhrzadeh L, Laskin JD, Laskin DL. Ozone-induced production of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50. Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L279–285. doi: 10.1152/ajplung.00348.2003. [DOI] [PubMed] [Google Scholar]
  • 112.Fakhrzadeh L, Laskin JD, Laskin DL. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am J Respir Cell Mol Biol. 2002 Apr;26(4):413–419. doi: 10.1165/ajrcmb.26.4.4516. [DOI] [PubMed] [Google Scholar]
  • 113.Laskin DL, Sunil V, Guo Y, Heck DE, Laskin JD. Increased nitric oxide synthase in the lung after ozone inhalation is associated with activation of NF-kappa B. Environ Health Perspect. 1998 Oct;106 (Suppl 5):1175–1178. doi: 10.1289/ehp.98106s51175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Kleeberger SR, Levitt RC, Zhang LY, et al. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat Genet. 1997 Dec;17(4):475–478. doi: 10.1038/ng1297-475. [DOI] [PubMed] [Google Scholar]
  • 115.Cho HY, Zhang LY, Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am J Physiol Lung Cell Mol Physiol. 2001 Mar;280(3):L537–546. doi: 10.1152/ajplung.2001.280.3.L537. [DOI] [PubMed] [Google Scholar]
  • 116.Shore SA, Schwartzman IN, Le Blanc B, Murthy GG, Doerschuk CM. Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med. 2001 Aug 15;164(4):602–607. doi: 10.1164/ajrccm.164.4.2001016. [DOI] [PubMed] [Google Scholar]
  • 117.Cho HY, Morgan DL, Bauer AK, Kleeberger SR. Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice. Am J Respir Crit Care Med. 2007 Apr 15;175(8):829–839. doi: 10.1164/rccm.200509-1527OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Yang IA, Holz O, Jorres RA, et al. Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function. Am J Respir Crit Care Med. 2005 Jan 15;171(2):171–176. doi: 10.1164/rccm.200402-194OC. [DOI] [PubMed] [Google Scholar]
  • 119.Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996 Mar 15;87(6):2095–2147. [PubMed] [Google Scholar]
  • 120.Moore PE, Lahiri T, Laporte JD, Church T, Panettieri RA, Jr, Shore SA. Selected contribution: synergism between TNF-alpha and IL-1 beta in airway smooth muscle cells: implications for beta-adrenergic responsiveness. J Appl Physiol. 2001 Sep;91(3):1467–1474. doi: 10.1152/jappl.2001.91.3.1467. [DOI] [PubMed] [Google Scholar]
  • 121.Wu ZX, Barker JS, Batchelor TP, Dey RD. Interleukin (IL)-1 regulates ozone-enhanced tracheal smooth muscle responsiveness by increasing substance P (SP) production in intrinsic airway neurons of ferret. Respir Physiol Neurobiol. 2008 Dec 31;164(3):300–311. doi: 10.1016/j.resp.2008.07.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Park JW, Taube C, Swasey C, et al. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol. 2004 Jun;30(6):830–836. doi: 10.1165/rcmb.2003-0373OC. [DOI] [PubMed] [Google Scholar]
  • 123.Johnston RA, Mizgerd JP, Flynt L, Quinton LJ, Williams ES, Shore SA. Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice. Am J Respir Cell Mol Biol. 2007 Oct;37(4):477–484. doi: 10.1165/rcmb.2006-0315OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Verhein KC, Jacoby DB, Fryer AD. IL-1 receptors mediate persistent, but not acute, airway hyperreactivity to ozone in guinea pigs. Am J Respir Cell Mol Biol. 2008 Dec;39(6):730–738. doi: 10.1165/rcmb.2008-0045OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today. 1997 Sep;18(9):428–432. doi: 10.1016/s0167-5699(97)01103-1. [DOI] [PubMed] [Google Scholar]
  • 126.Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994 Jan 1;83(1):113–118. [PubMed] [Google Scholar]
  • 127.DiCosmo BF, Geba GP, Picarella D, et al. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest. 1994 Nov;94(5):2028–2035. doi: 10.1172/JCI117556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Kuhn C, 3rd, Homer RJ, Zhu Z, et al. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol. 2000 Mar;22(3):289–295. doi: 10.1165/ajrcmb.22.3.3690. [DOI] [PubMed] [Google Scholar]
  • 129.Vincent R, Vu D, Hatch G, et al. Sensitivity of lungs of aging Fischer 344 rats to ozone: assessment by bronchoalveolar lavage. Am J Physiol. 1996 Oct;271(4 Pt 1):L555–565. doi: 10.1152/ajplung.1996.271.4.L555. [DOI] [PubMed] [Google Scholar]
  • 130.Shore SA, Johnston RA, Schwartzman IN, Chism D, Krishna Murthy GG. Ozone-induced airway hyperresponsiveness is reduced in immature mice. J Appl Physiol. 2002 Mar;92(3):1019–1028. doi: 10.1152/japplphysiol.00381.2001. [DOI] [PubMed] [Google Scholar]
  • 131.Samet JM, Hatch GE, Horstman D, et al. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med. 2001 Sep 1;164(5):819–825. doi: 10.1164/ajrccm.164.5.2008003. [DOI] [PubMed] [Google Scholar]
  • 132.Yu M, Zheng X, Witschi H, Pinkerton KE. The role of interleukin-6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Toxicol Sci. 2002 Aug;68(2):488–497. doi: 10.1093/toxsci/68.2.488. [DOI] [PubMed] [Google Scholar]
  • 133.Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton TA. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol. 1993 Mar;142(3):861–870. [PMC free article] [PubMed] [Google Scholar]
  • 134.Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002 Jan 1 2002;71(1):1–8. [PubMed] [Google Scholar]
  • 135.Devlin RB, McDonnell WF, Becker S, et al. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol Appl Pharmacol. 1996 May;138(1):176–185. doi: 10.1006/taap.1996.0111. [DOI] [PubMed] [Google Scholar]
  • 136.Kleeberger SR, Ohtsuka Y, Zhang LY, Longphre M. Airway responses to chronic ozone exposure are partially mediated through mast cells. J Appl Physiol. 2001 Feb;90(2):713–723. doi: 10.1152/jappl.2001.90.2.713. [DOI] [PubMed] [Google Scholar]
  • 137.Kleeberger SR, Seiden JE, Levitt RC, Zhang LY. Mast cells modulate acute ozone-induced inflammation of the murine lung. Am Rev Respir Dis. 1993 Nov;148(5):1284–1291. doi: 10.1164/ajrccm/148.5.1284. [DOI] [PubMed] [Google Scholar]
  • 138.Noviski N, Brewer JP, Skornik WA, Galli SJ, Drazen JM, Martin TR. Mast cell activation is not required for induction of airway hyperresponsiveness by ozone in mice. J Appl Physiol. 1999 Jan;86(1):202–210. doi: 10.1152/jappl.1999.86.1.202. [DOI] [PubMed] [Google Scholar]
  • 139.Goldstein E, Tyler WS, Hoeprich PD, Eagle C. Ozone and the antibacterial defense mechanisms of the murine lung. Arch Intern Med. 1971 Jun;127(6):1099–1102. [PubMed] [Google Scholar]
  • 140.Aranyi C, Vana SC, Thomas PT, et al. Effects of subchronic exposure to a mixture of O3, SO2, and (NH4)2SO4 on host defenses of mice. J Toxicol Environ Health. 1983 Jul;12(1):55–71. doi: 10.1080/15287398309530407. [DOI] [PubMed] [Google Scholar]
  • 141.Miller S, Ehrlich R. Susceptibility to respiratory infections of animals exposed to ozone. I. Susceptibility to Klebsiella pneumoniae. J Infect Dis. 1958 Sep-Oct;103(2):145–149. doi: 10.1093/infdis/103.2.145. [DOI] [PubMed] [Google Scholar]
  • 142.Thomas GB, Fenters JD, Ehrlich R, Gardner DE. Effects of exposure to ozone on susceptibility to experimental tuberculosis. Toxicol Lett. 1981 Sep;9(1):11–17. doi: 10.1016/0378-4274(81)90168-5. [DOI] [PubMed] [Google Scholar]
  • 143.Valentine R. An in vitro system for exposure of lung cells to gases: effects of ozone on rat macrophages. J Toxicol Environ Health. 1985;16(1):115–126. doi: 10.1080/15287398509530723. [DOI] [PubMed] [Google Scholar]
  • 144.Hollingsworth JW, Maruoka S, Li Z, et al. Ambient ozone primes pulmonary innate immunity in mice. J Immunol. 2007 Oct 1;179(7):4367–4375. doi: 10.4049/jimmunol.179.7.4367. [DOI] [PubMed] [Google Scholar]
  • 145.Li ZPE, Piantadosi CA, Foster WM, Hollingsworth JW. Hyaluronan fragments contribute to the ozone primed immune response to LPS. Journal of Immunology. 2010 doi: 10.4049/jimmunol.1000283. Ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  • 146.Getahun D, Demissie K, Rhoads GG. Recent trends in asthma hospitalization and mortality in the United States. J Asthma. 2005 Jun;42(5):373–378. doi: 10.1081/JAS-62995. [DOI] [PubMed] [Google Scholar]
  • 147.Fanta CH. Asthma. N Engl J Med. 2009 Mar 5;360(10):1002–1014. doi: 10.1056/NEJMra0804579. [DOI] [PubMed] [Google Scholar]
  • 148.Last JA, Ward R, Temple L, Pinkerton KE, Kenyon NJ. Ovalbumin-induced airway inflammation and fibrosis in mice also exposed to ultrafine particles. Inhal Toxicol. 2004 Feb;16(2):93–102. doi: 10.1080/08958370490265077. [DOI] [PubMed] [Google Scholar]
  • 149.Depuydt PO, Lambrecht BN, Joos GF, Pauwels RA. Effect of ozone exposure on allergic sensitization and airway inflammation induced by dendritic cells. Clin Exp Allergy. 2002 Mar;32(3):391–396. doi: 10.1046/j.1365-2222.2002.01364.x. [DOI] [PubMed] [Google Scholar]
  • 150.Wagner JG, Hotchkiss JA, Harkema JR. Enhancement of nasal inflammatory and epithelial responses after ozone and allergen coexposure in Brown Norway rats. Toxicol Sci. 2002 Jun;67(2):284–294. doi: 10.1093/toxsci/67.2.284. [DOI] [PubMed] [Google Scholar]
  • 151.Ozawa M, Fujimaki H, Imai T, Honda Y, Watanabe N. Suppression of IgE antibody production after exposure to ozone in mice. Int Arch Allergy Appl Immunol. 1985;76(1):16–19. doi: 10.1159/000233654. [DOI] [PubMed] [Google Scholar]
  • 152.Jorres R, Nowak D, Magnussen H. The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med. 1996 Jan;153(1):56–64. doi: 10.1164/ajrccm.153.1.8542163. [DOI] [PubMed] [Google Scholar]
  • 153.Kehrl HR, Peden DB, Ball B, Folinsbee LJ, Horstman D. Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J Allergy Clin Immunol. 1999 Dec;104(6):1198–1204. doi: 10.1016/s0091-6749(99)70013-8. [DOI] [PubMed] [Google Scholar]
  • 154.Bernstein JA, Alexis N, Barnes C, et al. Health effects of air pollution. J Allergy Clin Immunol. 2004 Nov;114(5):1116–1123. doi: 10.1016/j.jaci.2004.08.030. [DOI] [PubMed] [Google Scholar]
  • 155.Steerenberg PA, Garssen J, van Bree L, van Loveren H. Ozone alters T-helper cell mediated bronchial hyperreactivity and resistance to bacterial infection. Exp Toxicol Pathol. 1996 Nov;48(6):497–499. doi: 10.1016/S0940-2993(96)80065-0. [DOI] [PubMed] [Google Scholar]
  • 156.Van Loveren H, Steerenberg PA, Garssen J, Van Bree L. Interaction of environmental chemicals with respiratory sensitization. Toxicol Lett. 1996 Aug;86(2–3):163–167. doi: 10.1016/0378-4274(96)03686-7. [DOI] [PubMed] [Google Scholar]
  • 157.Stenfors N, Bosson J, Helleday R, et al. Ozone exposure enhances mast-cell inflammation in asthmatic airways despite inhaled corticosteroid therapy. Inhal Toxicol. 2010 Feb;22(2):133–139. doi: 10.3109/08958370903005736. [DOI] [PubMed] [Google Scholar]
  • 158.Meunier L, Bohjanen K, Voorhees JJ, Cooper KD. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. J Invest Dermatol. 1994 Dec;103(6):775–779. doi: 10.1111/1523-1747.ep12413014. [DOI] [PubMed] [Google Scholar]
  • 159.Lenschow DJ, Su GH, Zuckerman LA, et al. Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11054–11058. doi: 10.1073/pnas.90.23.11054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Freeman GJ, Borriello F, Hodes RJ, et al. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med. 1993 Dec 1;178(6):2185–2192. doi: 10.1084/jem.178.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Koike E, Kobayashi T. Ozone exposure enhances antigen-presenting activity of interstitial lung cells in rats. Toxicology. 2004 Mar 15;196(3):217–227. doi: 10.1016/j.tox.2003.10.007. [DOI] [PubMed] [Google Scholar]
  • 162.Koike E, Watanabe H, Kobayashi T. Exposure to ozone enhances antigen-presenting activity concentration dependently in rats. Toxicology. 2004 Apr 1;197(1):37–46. doi: 10.1016/j.tox.2003.12.007. [DOI] [PubMed] [Google Scholar]
  • 163.Lay JC, Alexis NE, Kleeberger SR, et al. Ozone enhances markers of innate immunity and antigen presentation on airway monocytes in healthy individuals. J Allergy Clin Immunol. 2007 Sep;120(3):719–722. doi: 10.1016/j.jaci.2007.05.005. [DOI] [PubMed] [Google Scholar]
  • 164.Delayre-Orthez C, de Blay F, Frossard N, Pons F. Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy. 2004 Nov;34(11):1789–1795. doi: 10.1111/j.1365-2222.2004.02082.x. [DOI] [PubMed] [Google Scholar]
  • 165.Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002 Dec 16;196(12):1645–1651. doi: 10.1084/jem.20021340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Redecke V, Hacker H, Datta SK, et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol. 2004 Mar 1;172(5):2739–2743. doi: 10.4049/jimmunol.172.5.2739. [DOI] [PubMed] [Google Scholar]
  • 167.Wan GH, Li CS, Lin RH. Airborne endotoxin exposure and the development of airway antigen-specific allergic responses. Clin Exp Allergy. 2000 Mar;30(3):426–432. doi: 10.1046/j.1365-2222.2000.00730.x. [DOI] [PubMed] [Google Scholar]
  • 168.Goldsmith CA, Hamada K, Ning Y, et al. Effects of environmental aerosols on airway hyperresponsiveness in a murine model of asthma. Inhal Toxicol. 1999 Nov;11(11):981–998. doi: 10.1080/089583799196646. [DOI] [PubMed] [Google Scholar]
  • 169.Stephens R, Chaplin DD. IgE cross-linking or lipopolysaccharide treatment induces recruitment of Th2 cells to the lung in the absence of specific antigen. J Immunol. 2002 Nov 15;169(10):5468–5476. doi: 10.4049/jimmunol.169.10.5468. [DOI] [PubMed] [Google Scholar]
  • 170.Alexis NE, Lay JC, Hazucha M, et al. Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans. Inhal Toxicol. 2010 Jun;22(7):593–600. doi: 10.3109/08958371003596587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Neuhaus-Steinmetz U, Uffhausen F, Herz U, Renz H. Priming of allergic immune responses by repeated ozone exposure in mice. Am J Respir Cell Mol Biol. 2000 Aug;23(2):228–233. doi: 10.1165/ajrcmb.23.2.3898. [DOI] [PubMed] [Google Scholar]
  • 172.Osebold JW, Gershwin LJ, Zee YC. Studies on the enhancement of allergic lung sensitization by inhalation of ozone and sulfuric acid aerosol. J Environ Pathol Toxicol. 1980 Jun-Jul;3(5–6):221–234. [PubMed] [Google Scholar]
  • 173.Osebold JW, Zee YC, Gershwin LJ. Enhancement of allergic lung sensitization in mice by ozone inhalation. Proc Soc Exp Biol Med. 1988 Jul;188(3):259–264. doi: 10.3181/00379727-188-42733. [DOI] [PubMed] [Google Scholar]
  • 174.Gershwin LJ, Osebold JW, Zee YC. Immunoglobulin E-containing cells in mouse lung following allergen inhalation and ozone exposure. Int Arch Allergy Appl Immunol. 1981;65(3):266–277. doi: 10.1159/000232766. [DOI] [PubMed] [Google Scholar]
  • 175.Schelegle ES, Miller LA, Gershwin LJ, et al. Repeated episodes of ozone inhalation amplifies the effects of allergen sensitization and inhalation on airway immune and structural development in Rhesus monkeys. Toxicol Appl Pharmacol. 2003 Aug 15;191(1):74–85. doi: 10.1016/s0041-008x(03)00218-7. [DOI] [PubMed] [Google Scholar]
  • 176.Biagini RE, Moorman WJ, Lewis TR, Bernstein IL. Ozone enhancement of platinum asthma in a primate model. Am Rev Respir Dis. 1986 Oct;134(4):719–725. doi: 10.1164/arrd.1986.134.4.719. [DOI] [PubMed] [Google Scholar]
  • 177.Medzhitov R, Janeway C., Jr Innate immune recognition: mechanisms and pathways. Immunol Rev. 2000 Feb;173:89–97. doi: 10.1034/j.1600-065x.2000.917309.x. [DOI] [PubMed] [Google Scholar]
  • 178.Hollingsworth JW, Free ME, Li Z, Andrews LN, Nakano H, Cook DN. Ozone activates pulmonary dendritic cells and promotes allergic sensitization through a Toll-like receptor 4-dependent mechanism. J Allergy Clin Immunol. 2010 May;125(5):1167–1170. doi: 10.1016/j.jaci.2010.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES